However, a recent study showed that various colorectal and breast cancer lines exposed to high concentrations of resveratrol upregulated the programed cell death ligand 1 (PD-L1), a molecule that promotes tumor evasion of immune responses by interacting with the death receptor PD-1 expressed on T-cells (Lucas et al., 2018). Here, CD274 is linked to breast cancer.